Resveratrol Attenuates Neuroinflammation and Myelination Deficits in Repeated Sevoflurane‐Exposed Neonatal Mice
- 9 April 2026
- journal article
- Published by Wiley in International Journal of Developmental Neuroscience
- Vol. 86 (2) , e70123
Abstract
Background: It is reported that repeated neonatal exposure to sevoflurane, a widely used volatile anaesthetic in paediatric anaesthesia, impairs cognitive and fine‐motor functions. Resveratrol has potent anti‐inflammatory and antioxidant properties; however, its role in sevoflurane‐induced hypomyelination is not known. Methods: Neonatal C57BL/6J mice were exposed to 3.5% sevoflurane 2 h daily for 3 consecutive days. Resveratrol of 30 mg/kg was administered intraperitoneally 1 h before each exposure. Cognitive and fine‐motor functions were evaluated by the Morris water maze and single‐pellet reaching task, respectively. Myelination and neuroinflammatory responses in the hippocampus and corpus callosum were examined using immunofluorescence and western blot analyses. In vitro primary microglia and oligodendrocyte precursor cells (OPCs) were used to assess microglia‐mediated inflammation on OPC differentiation. Furthermore, a selective Nrf2 inhibitor ML385 was co‐administered to understand the mechanistic role of resveratrol. Results: Repeated neonatal sevoflurane exposure impaired spatial learning/memory and fine‐motor performance, reduced myelin basic protein (MBP) expression and increased pro‐inflammatory marker (iNOS, CD86, IL‐1β and TNF‐α) expression in both hippocampus and corpus callosum. Resveratrol treatment ameliorated these deficits, evidenced by restoring MBP levels and improving behavioural outcomes. Mechanistically, resveratrol activated the Nrf2/HO‐1 pathway, suppressed microglial M1 polarization and normalized the microglial secretome, thereby promoting OPC differentiation, whereas ML385 attenuated these resveratrol's neuroprotective effects. Conclusions: Resveratrol mitigates sevoflurane‐induced OPCs differentiation impairments and hypomyelination via inhibiting microglial activation, which may be mediated by Nrf2/HO‐1 signalling.Keywords
Funding Information
- National Natural Science Foundation of China (81570073)
This publication has 27 references indexed in Scilit:
- Microglia-derived exosomes modulate myelin regeneration via activating Nrf2 signaling pathway in oligodendrocyte precursor cells in MSBrain, Behavior, and Immunity, 2025
- Myelination Trajectory and Microglial Dynamics Following Repeated Sevoflurane Exposure in Developing BrainGlia, 2025
- Inhibition of histamine receptor 3 alleviates sevoflurane-induced hypomyelination and neurobehavioral deficitsExperimental Neurology, 2024
- Repeated postnatal sevoflurane exposure impairs social recognition in mice by disrupting GABAergic neuronal activity and development in hippocampusBritish Journal of Anaesthesia, 2024
- Boosting Microglial Lipid Metabolism via TREM2 Signaling by Biomimetic Nanoparticles to Attenuate the Sevoflurane‐Induced Developmental NeurotoxicityAdvanced Science, 2023
- Neurobehavioral, biochemical and histological assessment of the effects of resveratrol on cuprizone-induced demyelination in mice: role of autophagy modulationJournal of Physiology and Biochemistry, 2023
- Resveratrol regulates inflammation and improves oxidative stress via Nrf2 signaling pathway: Therapeutic and biotechnological prospectsPhytotherapy Research, 2023
- Sulforaphane promotes white matter plasticity and improves long-term neurological outcomes after ischemic stroke via the Nrf2 pathwayFree Radical Biology and Medicine, 2022
- A clinical review of inhalation anesthesia with sevoflurane: from early research to emerging topicsJournal of Anesthesia, 2017
- Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanismCellular and Molecular Life Sciences, 2016